TRAP@NCI

Measuring the Cost of Lost Productivity Due to Premature Cancer-related Mortality: A European Overview

Hanly, Paul, Soerjomataram, Isabelle and Sharp, Linda (2013) Measuring the Cost of Lost Productivity Due to Premature Cancer-related Mortality: A European Overview. Value in Health, 16 (7). A324. ISSN 1098-3015

Full text not available from this repository.

Abstract

Objectives
To assess the economic burden of cancer by estimating years of potential productive life lost (YPPLL) and costs of lost productivity due to premature cancer-related mortality across Europe.

Methods
We derived the number of cancer deaths by sex for 23 of the most common cancer sites in 30 European countries from GLOBOCAN. YPPLL were calculated by multiplying the number of cancer-specific deaths for each productive age group (15-64) by standard life expectancy at the mid-point for each age group. Using the human capital approach, we multiplied standardised YPPLL for each individual by country- age- and gender-specific annual wages from age of death until retirement following adjustments for labour force participation and unemployment. Costs were expressed in 2008€.

Results
All cancer sites combined generated a total of €150.9 billion in premature mortality costs in Europe in 2008. Western Europe accounted for almost half of the total, followed by Northern (21%), Southern (21%) and Central & Eastern Europe (9%). Findings contrasted with YPPLL where Central & Eastern Europe had the highest burden. Male costs exceeded female costs by 88% in Europe as a whole (male: €98.4 billion; female: €52.5 billion) and across all European regions. Lung was the most expensive site (€34.7 billion; 23% of total costs), followed by breast cancer (€13.6 billion, 9%), colorectal cancer (€12.1 billion, 8%), brain & CNS (€9.1 billion, 6%) and pancreatic cancer (€7.5 billion, 5%). According to premature mortality cost per death, testicular cancer was the most expensive site (€2.5 million per death), followed by brain & CNS cancer (€481,512) and Hodgkin lymphoma (€474,559).

Conclusions
Lost productivity costs due to cancer-related premature mortality are significant in Europe. Productivity costs provide an alternative perspective on the cancer burden on society and may inform cancer control policy decisions.

Item Type: Article
Subjects: Q Science > Life sciences > Medical sciences > Pathology > Tumors > Cancer
H Social Sciences > Economics > Microeconomics > Production (Economic theory) > Industrial productivity > Labor productivity
Divisions: School of Business > Staff Research and Publications
Related URLs:
Depositing User: CAOIMHE NI MHAICIN
Date Deposited: 22 Oct 2016 15:45
Last Modified: 22 Oct 2016 15:45
URI: http://trap.ncirl.ie/id/eprint/2262

Actions (login required)

View Item View Item